Taxanes in Combination with Cisplatin and Fluorouracil for Advanced Penile Cancer: Preliminary Results

European Urology

Volumn 55, Issue 3, 2009, Pages 546-551

  Pizzocaro, Giorgio ^a,b   Nicolai, Nicola ^b   Milani, Angelo ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Advanced disease; Penile cancer; Taxanes and cisplatin fluorouracil

Indexed keywords

CISPLATIN; FLUOROURACIL; PACLITAXEL;

ADULT; AGED; ARTICLE; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER REGRESSION; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG TOLERABILITY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; MALE; METASTASIS; MULTIPLE CYCLE TREATMENT; NAUSEA AND VOMITING; PENIS CANCER; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PACLITAXEL; PENILE NEOPLASMS; TAXOIDS;

EID: 58849164140     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2008.07.014     Document Type: Article

References (18)

1. Culkin D.J., and Beer T.M. Advanced penile carcinoma. J Urol 170 (2003) 359-365
2. Pizzocaro G., Nicolai N., and Piva L. Chemotherapy for cancer of the penis. In: Raghavan D., Leibel S.A., Scher H.I., and Langhe P. (Eds). Principles and Practice of Genitourinary Oncology (1997), Lippincot-Raven Publishers, Philadelphia, PA 973-977
3. Hitt R., Lopez-Pousa A., Martinez-Trufero J., et al. Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer. J Clin Oncol 23 (2005) 8636-8645
4. Joerger M., Warzinak T., Klaeser B., et al. Major tumor regression after paclitaxel and carboplatin polychemotherapy in a patient with advanced penile cancer. Urology 63 (2004) 778-780
5. 2 laser excision for conservative treatment of in situ and T1 penile carcinoma: report on 224 patients. Eur Urol 54 (2008) 875-884
6. Pizzocaro G., and Piva L. Adjuvant and neoadjuvant vincristine, bleomycin and methotrexate for inguinal metastases from squamous cell carcinoma of the penis. Acta Oncol 27 (1988) 823-824
7. Molinari R., Mattavelli F., Cantù G., et al. Results of a low-dose combination chemotherapy with vincristine, bleomycin and methotrexate (V-B-M) based on cell kinetics in the palliative treatment of head and neck squamous cell carcinoma. Eur J Cancer 16 (1980) 469-472
8. Ussein A.M., Benedetto P., and Sridan K.S. Chemotherapy with cisplatin and 5-fluorouracil for penile and urethral squamous cell carcinoma. Cancer 65 (1990) 433-438
9. Shammas F., Ous S., and Fossa S. Cisplatin and 5-fluorouracil in advanced cancer of the penis. J Urol 147 (1992) 630-632
10. Weaver A., Fleming S., Vandenberg H., et al. Cis-platinum and 5-fluorouracil as initial therapy in advanced epidermoid cancers of head and neck. Head Neck Surg 4 (1982) 370-373
11. Dexeus F., Logothetis C., Sella A., et al. Combination chemotherapy with methotrexate, bleomycin and cisplatin for advanced squamous cell carcinoma of the male genital tract. J Urol 146 (1991) 1284-1287
12. Haas G., Blumenstein B., Gagliano R., et al. Cisplatin, methotrexate and bleomycin for the treatment of carcinoma of the penis: a Southwest Oncology Group study. J Urol 161 (1999) 1823-1825
13. Hakenberg O.W., Nippgen J.B., Froehner M., et al. Cisplatin methotrexate and bleomycin for treating advanced penile carcinoma. Brit J Urol Int 98 (2006) 1225-1227
14. Leijte J.A.P., Kerst J.M., Bais E., et al. Neoadjuvant chemotherapy in advanced penile carcinoma. Eur Urol 52 (2007) 488-494
15. Barmejo C., Busby J.K., Spiess P.E., et al. Neoadjuvant chemotherapy followed by aggressive surgical consolidation for metastatic penile squamous cell carcinoma. J Urol 177 (2007) 1335-1338
16. Posner M.R., Hershock D.M., Blajman C.R., et al. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med 357 (2007) 1705-1715
17. Vermorkem J.B., Remenar E., van Herpen C., et al. Cisplatin, fluorouracil and docetaxel in unresectable head and neck cancer. N Engl J Med 357 (2007) 1695-1704
18. Pizzocaro G. Editorial comment on: Neoadjuvant chemotherapy in advanced penile carcinoma. Eur Urol 52 (2007) 494